EBioMedicine,
Journal Year:
2023,
Volume and Issue:
97, P. 104830 - 104830
Published: Oct. 12, 2023
More
than
two
years
have
now
elapsed
since
the
COVID-19
vaccination
was
first
authorized
and
administered
worldwide.
Over
time,
evidence
on
vaccines
has
been
continuously
reviewed
by
regulatory
bodies
leading
to
progressive
inclusion
of
even
more
susceptible
groups
(i.e.,
infants,
pregnant
breastfeeding
women).
The
initial
lack
consensus,
in
concert
with
absence
any
preliminary
data
about
mRNA
vaccine
transfer
persistence
breast
milk
(BM),
determined
hesitancy
low
compliance
among
mothers.
In
this
issue
eBioMedicine,
Hanna
colleagues
attempted
put
final
word
biodistribution,
fragmentation
biological
activity
BM.1Hanna
N.
Manzano
de
Mejia
C.
Heffes-Doon
A.
et
al.Biodistribution
human
milk.EBioMedicine.
2023;
96104800https://doi.org/10.1016/j.ebiom.2023.104800Summary
Full
Text
PDF
PubMed
Scopus
(0)
Google
Scholar
They
demonstrated
that
does
not
persist
injection
site
but
can
be
systemically
spread,
being
mainly
packaged
into
BM
extracellular
vesicles
(EVs).
addition,
they
definitively
reported
presence
BM,
although
displaying
large
very
little
translational
activity.
Recent
scientific
literature
focused
determining
functionality
anti-Spike
protein
antibodies
vaccinated
women,2Rosenberg-Friedman
M.
Kigel
Bahar
Y.
al.BNT162b2
elicited
antibody
response
blood
women.Nat
Commun.
2021;
12:
6222Crossref
(30)
Scholar,3Agostinis
Toffoli
Balduit
al.Anti-spike
present
SARS-CoV-2
mothers
are
complement-activating.Int
J
Mol
Sci.
24:
4395Crossref
(2)
only
few
studies
investigated
levels
BNT162b2
or
mRNA-1273
BM.4Shook
L.L.
Edlow
A.G.
Safety
efficacy
coronavirus
disease
2019
(COVID-19)
during
lactation.Obstet
Gynecol.
141:
483-491Crossref
(5)
Golan
al.,
analyzing
13
samples
collected
from
7
women
24
h
after
-including
multiple
time
points,
up
48
h,
a
single
participant-have
initially
neglected
vaccine-associated
mRNA.5Golan
Prahl
Cassidy
al.Evaluation
messenger
RNA
BTN162b2
milk.JAMA
Pediatr.
175:
1069-1071Crossref
(35)
Low
al.
instead
minimal
at
sub-picogram
level
approximately
10%
BM:
highest
concentration
detected
2
ng/mL,
which
would
consistent
0.667%
original
dose
100
mL
BM.6Low
J.M.
Gu
Ng
M.S.F.
al.Codominant
IgG
IgA
expression
vaccinees.NPJ
Vaccines.
6:
105Crossref
(44)
Yeo
also
transient
intact
5/309
(2%)
samples,
serum
breastfed
infants.7Yeo
K.T.
Chia
W.N.
Tan
C.W.
al.Neutralizing
breastmilk
lactating
women.Front
Immunol.
12783975Google
It
is
worthwhile
mention
limited
sample
sizes,
sensitivity
techniques
storage
may
significant
impact
results
these
studies.
ultimate
convincing
for
precisely
study
154
were
individuals
different
intervals
and/or
booster
dose.1Hanna
group
small
amounts
15
post-injection.
Interestingly,
provided
packaging
EVs
isolated
supernatants,
as
previously
anticipated
same
group,8Hanna
Lin
X.
al.Detection
2022;
176:
1268-1270Crossref
(19)
approximatively
12–90%
found
EV
fraction.
Similar
findings
paved
way
proposal
new
model
biodistribution
intramuscular
injection,
lipid
nanoparticles
enclosing
diffuse
mammary
glands
via
hematic
lymphatic
pathways;
within
cells,
developing
released
BM.
surprising
researchers
working
nanoparticles,
off-target
distribution
major
formulations
last
decade.9Carrasco
M.J.
Alishetty
S.
Alameh
M.G.
al.Ionization
structural
properties
influence
intravascular
administration.Commun
Biol.
4:
956Crossref
(92)
authors
moved
step
further
other
previous
publications
field
exploring
potential
integrity
mRNA.
Assuming
EVs,
resistant
gastric
pancreatic
digestion
retain
capability
enter
intestinal
cells
vitro,10Liao
Du
Li
J.
Lönnerdal
B.
Human
exosomes
their
microRNAs
survive
vitro
taken
cells.Mol
Nutr
Food
Res.
2017;
61https://doi.org/10.1002/mnfr.201700082Crossref
(209)
decisive
breakthrough
consists
demonstration
residual
unable
induce
Spike
EV-treated
HT-29
cells.
This
likely
due
poor
it
reduced
12–25%
duplex
droplet
digital
PCR
(ddPCR)
using
probes
targeting
flanks
vaccine.
We
like
particularly
point
out
had
great
merit
overcoming
some
technical
limitations
research,
ddPCR
linkage
assays,
use
distinct
set
primers
allowed
specific
sensitive
respective
mRNAs.
should
keep
mind
detection
synonymous
harm,
suggested
its
scarce
benefits
maternal
lactation
mother-infant
dyad
outweigh
conceivable
hazards,
accordance
recommendations
governmental
health
agencies.
accumulating
evidence,
particular
emerging
current
study,
allows
us
reasonably
assert
danger
newborns
is,
say
least,
remote;
however,
safety
needed
shed
light
fate
BM-derived
infant's
body
provide
still
controversial
issue.
Andrea
Chiara
Agostinis:
conceptualization
draft
preparation.
Roberta
Bulla:
review
editing.
declare
no
conflict
interest.
work
supported
Italian
Ministry
Health,
through
contribution
given
Institute
Maternal
Child
Health
IRCCS
Burlo
Garofolo-Trieste,
Italy.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
12(1), P. 59 - 59
Published: Dec. 26, 2023
Explosive
developments
in
mRNA
vaccine
technology
the
last
decade
have
made
it
possible
to
achieve
great
success
clinical
trials
of
vaccines
prevent
infectious
diseases
and
develop
cancer
treatments
mRNA-based
gene
therapy
products.
The
approval
mRNA-1273
BNT162b2
against
SARS-CoV-2
by
U.S.
Food
Drug
Administration
has
led
mass
vaccination
(with
vaccines)
several
hundred
million
people
around
world,
including
children.
Despite
its
effectiveness
fight
COVID-19,
rare
adverse
effects
been
shown
some
studies,
vascular
microcirculation
disorders
autoimmune
allergic
reactions.
biodistribution
remains
one
most
poorly
investigated
topics.
This
mini-review
discussed
results
recent
experimental
studies
on
humans
rodents
regarding
vaccines,
their
constituents
(mRNA
lipid
nanoparticles),
encoded
antigens.
We
focused
dynamics
products
possibility
crossing
blood–brain
blood–placental
barriers
as
well
transmission
infants
through
breast
milk.
In
addition,
we
critically
assessed
strengths
weaknesses
detection
methods
that
applied
these
articles,
whose
results’
reliability
is
becoming
a
subject
debate.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 454 - 454
Published: Feb. 16, 2023
Pregnant
women
are
at
higher
risk
of
severe
Coronavirus
disease
2019
(COVID-19)
complications
than
non-pregnant
women.
The
initial
exclusion
pregnant
from
anti-SARS-CoV-2
vaccines
clinical
trials
has
caused
a
lack
conclusive
data
about
safety
and
efficacy
for
this
vulnerable
population.
This
cross-sectional
study
aims
to
define
the
factors
related
vaccination
adherence
in
sample
experiencing
high-risk
pregnancies.
recruited
completed
questionnaire
based
on
Health
Belief
Model.
Data
were
analyzed
evaluate
associations
between
socio-demographic
variables
acceptance
through
descriptive,
univariate
multivariate
logistic
analyses.
Among
233
enrolled,
65.2%
(n
=
152)
declared
that
they
would
accept
vaccine.
Multivariate
analysis
showed
was
associated
with
high
educational
level
(aOR
4.52,
p
0.001),
low
perception
barriers
1.58,
0.005)
gynecologist’s
advice
3.18,
0.01).
About
third
still
hesitant
vaccine,
probably
because
conflicting
information
received
media,
friends,
acquaintances
health
institutions.
Determining
linked
vaccine
hesitancy
among
is
useful
creating
strategies
increase
uptake.
British Journal of Clinical Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 6, 2025
Aims
We
aimed
to
describe
suspected
adverse
drug
reactions
(ADRs)
in
infants
resulting
from
medications
transmitted
through
mothers'
milk,
as
reported
the
European
ADR
database,
EudraVigilance.
The
research
sought
understand
frequency,
seriousness
and
nature
of
these
ADRs
assess
potential
risks
associated
with
maternal
medication
use
during
breastfeeding.
Methods
Data
EudraVigilance
were
analysed.
study
included
all
be
related
milk
1
January
2013
July
2023.
data
categorized
by
reporting
time,
infant
age
sex,
type
ADR,
involved.
Results
A
total
922
breastfed
infants.
Serious
accounted
for
133
cases
(14%),
15
fatalities,
primarily
methadone
(
n
=
11)
diamorphine
3).
COVID‐19
vaccines
linked
half
reports
479,
52%),
while
serious
mainly
nervous
system
drugs
73,
43%),
particularly
anticonvulsants
opioids.
Most
511,
55%)
occurred
aged
between
month
year.
Conclusions
over
a
decade,
compared
estimated
millions
exposed
via
annually
Europe,
suggests
very
low
rate
ADRs.
This
finding
emphasizes
significant
challenges
postmarketing
surveillance
that
underreporting
remains
critical
concern
pharmacovigilance.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(5), P. 1090 - 1090
Published: April 29, 2023
With
COVID-19
vaccination
hesitancy
at
around
50%
in
the
obstetric
population,
it
is
critical
to
identify
which
women
should
be
addressed
and
how.
Our
study
aimed
assess
willingness
among
pregnant
postpartum
Europe
investigate
associated
determinants.
This
was
a
cross-sectional,
web-based
survey
conducted
Belgium,
Norway,
Switzerland,
The
Netherlands,
United
Kingdom
(UK)
June–August
2021.
Among
3194
women,
proportions
of
vaccinated
or
willing
ranged
from
80.5%
Belgium
21.5%
Norway.
characteristics
were
country
residence,
chronic
illness,
history
flu
vaccine,
trimester
pregnancy,
belief
that
more
severe
during
vaccine
effective
safe
pregnancy.
1659
86.0%
UK
58.6%
Switzerland.
determinants
breastfeeding,
breastfeeding.
Vaccine
population
depends
on
medical
especially
opinion
residence.
Journal of Perinatal Medicine,
Journal Year:
2024,
Volume and Issue:
52(6), P. 567 - 574
Published: May 14, 2024
After
more
than
4
years
of
the
SARS-CoV-2
pandemic,
a
great
deal
knowledge
on
how
this
virus
affects
pregnant
women,
fetus
and
newborn
has
accumulated.
Guidelines
for
mode
delivery,
cord
clamping,
skin
to
skin,
breastfeeding,
rooming-in
have
become
uniform
across
world.
Vaccination
considerably
improved
outcomes,
but
hesitancy
amongst
patients
emergence
variants
remain
challenged
positivity
during
pregnancy
continues
be
associated
with
an
increased
risk
maternal
complications,
premature
delivery
higher
neonatal
mortality
morbidity.
An
emerging
body
data
now
exists
effect
in
early
medical
education
obstetrics
pediatrics,
longer-term
developmental
outcomes.
In
article,
we
review
development
field
since
our
last
review.
Developmental medico-life-sciences,
Journal Year:
2024,
Volume and Issue:
1(2), P. 8 - 19
Published: May 28, 2024
Abstract
Background:
The
ongoing
global
health
challenge
posed
by
the
COVID-19
pandemic
has
necessitated
a
thorough
examination
of
vaccine
efficacy,
particularly
transfer
vaccine-induced
immunity
to
infants
via
human
milk.
This
meta-analysis
aims
explore
persistence
and
efficacy
antibodies
in
milk,
offering
insights
into
passive
breastfeeding
infants.
Methods:
We
conducted
systematic
review
peer-reviewed
studies
published
from
January
2021
December
2023,
extracted
databases
such
as
PubMed,
Scopus,
Web
Science.
Our
focus
was
on
measuring
SARS-CoV-2-specific
(IgA
IgG)
milk
following
maternal
vaccination.
Results:
Fifteen
involving
1,200
lactating
mothers
who
received
mRNA
vaccines
were
included.
analysis
highlighted
consistent
presence
IgA
IgG
persisting
for
up
six
months
post-vaccination.
Conclusion:
results
highlight
noteworthy
transmission
suggesting
an
extended
duration
possible
protection
neonates
against
SARS-CoV-2
infection.
argues
favor
immunizing
nursing
preemptive
public
strategy
provide
their
children
immunity.
Open Forum Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
10(5)
Published: April 13, 2023
Abstract
Background
Despite
high
rates
of
coronavirus
disease
2019
(COVID-19)-related
maternal
mortality,
Jamaica
currently
has
little
data
on
COVID-19
vaccine
uptake
among
pregnant
women.
Methods
We
conducted
a
cross-sectional,
web-based
survey
192
reproductive-aged
women
in
from
February
1
to
8,
2022.
Participants
were
recruited
convenience
sample
patients,
providers,
and
staff
at
teaching
hospital.
assessed
self-reported
vaccination
status
COVID-19-related
medical
mistrust
(operationalized
as
confidence,
government
mistrust,
race-based
mistrust).
used
multivariable
modified
Poisson
regression
test
the
association
between
pregnancy.
Results
Of
respondents,
72
(38%)
pregnant.
Most
(93%)
Black.
Vaccine
was
35%
versus
75%
nonpregnant
Pregnant
more
likely
cite
healthcare
providers
trustworthy
sources
information
(65%
vs
28%).
Pregnancy,
low
associated
with
lower
likelihood
(adjusted
prevalence
ratio
[aPR]
=
0.68
[95%
confidence
interval
{CI},
.49–.95],
aPR
0.61
CI,
.40–.95],
.52–.89],
respectively).
Race-based
not
final
model.
Conclusions
Jamaica.
Future
studies
should
evaluate
efficacy
strategies
proven
improve
coverage,
including
standing
“opt-out”
orders
collaborative
provider
patient-led
educational
videos
tailored
for
individuals.
Strategies
that
decouple
messaging
agencies
also
warrant
evaluation.
Medicine,
Journal Year:
2023,
Volume and Issue:
102(34), P. e34805 - e34805
Published: Aug. 25, 2023
Coronavirus
disease
2019
(COVID-19)
has
ravaged
the
world
since
December
2019.
Up
to
now,
it
is
still
prevalent
around
world.
Vaccines
are
an
important
means
prevent
spread
of
COVID-19
and
reduce
severe
mortality.
Currently,
different
types
novel
coronavirus
vaccines
being
developed
improved,
relevant
that
have
been
approved
for
marketing
widely
vaccinated
As
vaccination
coverage
continues
grow,
concerns
about
efficacy
safety
after
real-world
use
grown.
Some
clinical
studies
shown
vaccine
effectiveness
closely
related
antibody
response
vaccination.
Among
them,
advantages
messenger
ribonucleic
acid
(mRNA)
vaccine,
such
as
better
adaptability
variant
strains
immune
ability,
attracted
great
attention.
However,
populations
with
genders,
ages,
previous
infection
history,
underlying
diseases
treatments
will
show
responses
mRNA
vaccination,
which
affect
protection
vaccine.
Based
on
this,
this
paper
reviews
reports
acute
respiratory
syndrome
2
vaccines,
summarizes
in
states
looked
forward
precise
strategy
future.